Tag: DEP oncology drug
Starpharma inks second deal with global pharmaceutical giant
Australian company Starpharma has signed a milestone deal with global pharmaceutical giant AstraZeneca to further develop a Dendrimer Enhanced Product (DEP) version of one...
Featured Article
Smarter energy decisions: GridBeyond unveils AI-powered Bid Optimiser in Australia
As Australia’s energy transition accelerates, businesses participating in the National Electricity Market (NEM) are facing growing challenges in managing their energy assets efficiently.
